Quantification of additional short arms of chromosome 12 in germ cell turnouts using the polymerase chain reaction

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1488-1494

  Malek, N P ^a   Casper, J ^a   Looijenga, L H J ^b   Strohmeyer, T ^c   Schmoll, H J ^a   Nordheim, A ^a   Janknecht, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c BAYER PHARMA AG   (Germany)

Author keywords

Carcinoma of uncertain histology; Germ cell tumour; Isochromosome 12p; Molecular diagnosis; Polymerase chain reaction

Indexed keywords

ARTICLE; CHROMOSOME 12P; DISEASE SEVERITY; FLUORESCENCE IN SITU HYBRIDIZATION; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY;

CHROMOSOMES, HUMAN, PAIR 12; GERMINOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCHROMOSOMES; KARYOTYPING; MALE; POLYMERASE CHAIN REACTION; TESTICULAR NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030776442     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00152-4     Document Type: Article

References (35)

1. Einhorn LH. Treatment of testicular cancer: a new and improved model. Clin Oncol 1990, 8, 1777-1781.
2. Heimdal K, Fossa SD, Johannsen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987. Br J Cancer 1990, 62, 277-278.
3. Zatonski W, Jeziorski K, Tyezynski J. Testicular cancer in Poland. Lancet 1990, 336, 183.
4. Atkin NB, Baker MC. Specific chromosome change, i(12p) in testicular tumors? Lancet 1982, 2, 349.
5. Atkin NB, Baker MC. i(12p): Specific chromosomal marker in seminomas and malignant teratoma of the testis? Cancer Genet Cytogenet 1983, 10, 199-204.
6. Delozier-Blanchet CD, Engel E, Walt H. Isochromosome 12p in malignant testicular tumors. Cancer Genet Cytogenet 1985, 15, 375-376.
7. Castedo SMMJ, de Jong B, Oosterhuis JW, et al. Chromosomal changes in human primary testicular nonseminomatous germ cell tumors. Cancer Res 1989, 49, 5695-5701.
8. Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl G, Chaganti RSK. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 1992, 52, 2285-2291.
9. Vos A, Oosterhuis JW, de Jong B, Buist J, Koops HS. Cytogenetics of carcinoma in situ of the testis. Cancer Genet Cytogenet 1990, 46, 75-81.
10. de Jong B, Oosterhuis JW, Castedo SM, Vos A, te Meerman GJ. Pathogenesis of adult testicular germ cell tumors: a cytogenetic model. Cancer Genet Cytogenet 1990, 48, 143-167.
11. Oosterhuis JW, Castedo SM, de Jong B. Cytogenetics, ploidy and differentiation of human testicular, ovarian and extragonadal germ cell tumors. Cancer Surv 1990, 9, 320-332.
12. Geurts-van-Kessel A, Suijkerbuijk RF, Sinke RK, Looijenga L, Oosterhuis JW, de Jong B. Molecular cytogenetics of human germ cell tumours: i(12p) and related chromosomal anomalies. Eur Urol 1993, 23, 23-8.
13. Rodriguez E, Houldsworth J, Reuter VE, et al. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer 1993, 8, 230-236.
14. Suijkerbuijk RF, Sinke RJ, Meloni AM, et al. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 1993, 70, 85-93.
15. Oliver RTD. Atrophy, hormones, genes and viruses in aetiology of germ cell tumors. Cancer Surv 1990, 9, 263-286.
16. Hanson PR, Belitsky P, Millard OH, Lannon SG. Prognostic factors in metastatic nonseminomatous germ cell tumours. Can J Surg 1993, 36, 537-540.
17. Bosl GJ, Dimitrovsky E, Reuter VE, et al. Isochromosome of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst 1989, 81, 1874-1878.
18. Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RSK. Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst 1994, 86, 349-355.
19. Murkherjee AB, Murty V, Rodriguez E, Bosl JG, Chaganti RSK. Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridisation. Genes Chromosomes Cancer 1991, 3, 300-307.
20. Suijkerbuijk RF, Looijenga L, de Jong B, Oosterhuis JW, Cassiman JJ, van Kessel G. Verification of isochromosome 12p and identification of other chromosome 12 aberrations in gonadal and extragonadal human germ cell tumors by bicolor double fluorescence in situ hybridisation. Cancer Genet Cytogenet 1992, 63, 8-16.
21. Dimitrovksy E, Murty V, Moy D, et al. Isochromosome 12p in non-seminoma cell lines: kariologic amplifications of c-ki-ras without point-mutational activation. Oncogene 1990, 5, 543-548.
22. Casper J, Bronson DL, Schnaidt U, Fonatsch C, Schmoll H-J. Menschliche Keimzellinien: in vitro und in vivo-Untersuchungen. Diagnostik und Therapie von Hodentumoren. Berlin-Heidelberg, Springer-Verlag, 1988, 537-543.
23. Nakamura Y, Ballard L, O'Connell P, et al. Isolation and mapping of a polymorphic DNA sequence pYNH15 on chromosome 12q [D12S17]. Nucleic Acids Res 1988, 16, 779.
24. McGrath JP, Capon DJ, Smith DH, et al. Structure and organisation of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature 1983, 304, 501-500.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 1989.
26. Wang HC, Fedoroff S. Banding in human chromosomes treated with trypsin. Nature 1972, 235, 52-54.
27. Gilliand G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990, 87, 2725-2729.
28. Siebert D, Larrick JW. Competitive PCR. Nature 1992, 359, 557-558.
29. Sandberg AA, Turc-Carel C. The cytogenetics of solid tumors. Cancer 1987, 59, 387-395.
30. Wang LC, Vass W, Gao C, Chang KKS. Amplification and enhanced expression of the c-Ki-ras-2 proto-oncogene in human embryonal carcinomas. Cancer Res 1987, 47, 4192-4198.
31. de Graaf WE, Oosterhuis JW, de Jong B, et al. Ploidy of carcinoma in situ. Lab Invest 1992, 66, 166-168.
32. Motzer RJ, Rodriguez E, Reuter VE, et al. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst 1991, 83, 341-346.
33. Mostert MMC, Van der Pol M, van Echten J, et al. Fluorescence in situ hybridisation-based approaches for detection of over-representation in particular i(12p) in cell lines of human testiculargerm cell tumours of adults. Cancer Genet Cytogenet 1996, 87, 95-102.
34. Mostert MMC, Van de Pol M, Olde Weghuis D, et al. Comperative genomic hybridisation of germ cell tumours of the adult testis: confirmation of karyotypic findings and identification of a 12p amplicon. Cancer Genet Cytogenet 1996, 89, 146-152.
35. van Echten J, Oosterhuis JW, Looijenga LHJ, et al. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumours of the testis. Genes Chromosomes Cancer 1995, 14, 133-144.